Reet Koomägi
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
Papers in
-
- Angiogenesis and VEGF in Cancer 14
- RNA modifications and cancer 8
- Kruppel-like factors research 5
- Oncology 27
- Cancer-related Molecular Pathways 12
- Co-authors
- M Volm (49 shared papers)J Mattern (28 shared papers)G. Stammler (8 shared papers)Jürgen Mattern (8 shared papers)Thomas Efferth (6 shared papers)M Volm (6 shared papers)Axel Sauerbrey (6 shared papers)Werner Rittgen (3 shared papers)
In The Last Decade
Reet Koomägi
58 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 558
- Oncology 647
- Molecular Biology 1.2k
- Internal Medicine 53
- Hematology 158
Countries citing papers authored by Reet Koomägi
This map shows the geographic impact of Reet Koomägi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reet Koomägi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reet Koomägi more than expected).
Fields of papers citing papers by Reet Koomägi
This network shows the impact of papers produced by Reet Koomägi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reet Koomägi. The network helps show where Reet Koomägi may publish in the future.
Co-authors
The 25 scholars most cited alongside Reet Koomägi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 279 | |
| 2 | 1997 | 198 | |
| 3 | Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. | 2000 | 177 |
| 4 | 1998 | 121 | |
| 5 | 1997 | 88 | |
| 6 | 1997 | 69 | |
| 7 | 1995 | 67 | |
| 8 | Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. | 2001 | 65 |
| 9 | Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. | 2000 | 63 |
| 10 | Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. | 2001 | 61 |
| 11 | 2000 | 58 | |
| 12 | 2002 | 56 | |
| 13 | Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. | 2002 | 49 |
| 14 | Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. | 1997 | 48 |
| 15 | UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. | 2001 | 46 |
| 16 | Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. | 2000 | 45 |
| 17 | Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. | 1997 | 42 |
| 18 | PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. | 1999 | 41 |
| 19 | 1997 | 39 | |
| 20 | Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. | 1999 | 39 |
About Reet Koomägi
Reet Koomägi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Biotechnology, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (14 papers), Cancer-related Molecular Pathways (12 papers), Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer, Lipids, and Metabolism (7 papers), Kruppel-like factors research (5 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Cancer Research (558 citations), Oncology (647 citations), Molecular Biology (1.2k citations), Internal Medicine (53 citations) and Hematology (158 citations). Reet Koomägi has collaborated with scholars based in Germany, Estonia and Iran. Frequent co-authors include M Volm, J Mattern, G. Stammler, Jürgen Mattern, Thomas Efferth, M Volm, Axel Sauerbrey, Werner Rittgen, Monica Hollstein and Abdolamir Allameh. Their work appears in journals such as International Journal of Oncology, International Journal of Cancer, Oncology Reports, British Journal of Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.